I think what folks are saying is that there are other ways for CIHR to in fact tap into the private sector expertise, and there are advisory bodies, and there are other ways in which we can benefit from your expertise based in the commercial sector. But I think an appointment of this nature on the governing council tells folks that in fact we're prepared to undermine the independence of the body and open up a possible trend in terms of commercialization on what should be absolutely neutral, independent bodies, particularly when it comes to drug companies--
On November 30th, 2009. See this statement in context.